» Articles » PMID: 39572031

Hearing Impairment Following Surgically Repaired Congenital Heart Disease in Children: a Prospective Study

Abstract

Objectives: To determine the prevalence of sensorineural hearing loss (SNHL) in children who underwent congenital cardiac surgery (CCS) by using a pre- and postoperative hearing test, a conventional audiometry, an extended high-frequency audiometry (HFA) or auditory steady-state response (ASSR), and distortion-product otoacoustic emissions (DPOAE).

Study Design: This prospective study enrolled children with CCS in Siriraj Hospital, Thailand, between 2019 and 2023. Conventional audiometry including HFA or ASSR and DPOAE were performed pre- and postoperatively. The patients with bilateral abnormal hearing loss or an incomplete examination were excluded. Collected data included: demographics, cardiac surgery and ototoxic medication. Prevalence of SNHL by conventional audiometry and subclinical hearing impairment by HFA or DPOAE were ascertained, and risks were analysed.

Results: Ninety-eight patients were eligible for the study. The median age (IQR) was 5.3 (1.5-9.6) years. Fifteen patients (15.3%) had univentricular hearts. The preoperative audiologic test was performed 1 day prior to the CCS. The postoperative test was performed at a median of 4.4 (IQR: 2.7-8.0) months postoperatively. Preoperative unilateral hearing impairments were reported in 17 patients (17.3%). Postoperatively, four patients (4.1%) showed significantly abnormal audiogram (> 25 dB) or 15 dB shift at 250-8000 Hz consistent to a new SNHL. Subclinical hearing impairment by HFA was affected in 10 patients (10.2%). Thirty-three patients (33.6%) had abnormal DPOAE exclusively. Therefore, new SNHL, including subclinical hearing loss, revealed a prevalence of ototoxicity up to 47.9%. Age <1 year at surgery was the independent risk of postoperative SNHL (adjusted OR 18.5, 95% CI 1.2 to 293.8, p=0.04).

Conclusion: Routine post-CCS audiological surveillance especially CCS in infancy is recommended for early recognition and timely management based on the 43.8% subclinical and the 4.1% SNHL that was found in this study.

Trial Registration Number: TCTR20200421001.

References
1.
Yang T, Fan X, Fan Y, Song W, Liu X, Wang J . Co-Occurrence of Sensorineural Hearing Loss and Congenital Heart Disease: Etiologies and Management. Laryngoscope. 2023; 134(1):400-409. DOI: 10.1002/lary.30799. View

2.
Deltenre P, Van Maldergem L . Hearing loss and deafness in the pediatric population: causes, diagnosis, and rehabilitation. Handb Clin Neurol. 2013; 113:1527-38. DOI: 10.1016/B978-0-444-59565-2.00023-X. View

3.
Olusanya B, Davis A, Hoffman H . Hearing loss grades and the . Bull World Health Organ. 2019; 97(10):725-728. PMC: 6796665. DOI: 10.2471/BLT.19.230367. View

4.
Robertson C, Tyebkhan J, Peliowski A, Etches P, Cheung P . Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr. 2006; 95(2):214-23. DOI: 10.1080/08035250500294098. View

5.
Alzahrani M, Tabet P, Saliba I . Pediatric hearing loss: common causes, diagnosis and therapeutic approach. Minerva Pediatr. 2014; 67(1):75-90. View